Get latest articles and stories on Business at LatestLY. To enable knowledge-sharing around Cervical cancer screening including the benefits of early screening with extended genotyping, BD (Becton, Dickinson, and Company) recently organized the Shape the future of Cervical Cancer screening discussion forum for pathologists, obstetricians, and gynecologists in Varanasi and Delhi-NCR. The Program was organized in association with the Association of Obstetricians and Gynaecologists of Delhi (AOGD), the Indian Society of Colposcopy and Cervical Pathology (ISCCP), and The Association of Gynecologic Oncologists of India (AGOI), Forum of obstetricians and gynecologists of south Delhi (FOGSd). Business News | BD India Hosted Discussion Forum on Cervical Cancer Screening Provides Best Practices Knowledge-Sharing Platform to Pathologists and Gynecologists.
New Delhi [India], December 19 (ANI/NewsVoir): To enable knowledge-sharing around Cervical cancer screening including the benefits of early screening with extended genotyping, BD (Becton, Dickinson, and Company) recently organized the Shape the future of Cervical Cancer screening discussion forum for pathologists, obstetricians, and gynecologists in Varanasi and Delhi-NCR
Search jobs 05-May-2021 Latest Study on Cervical Cancer Diagnostic Tests Market 2021 | Global Industry Size, Hinder Growth, Global Trend, Revenue, Manufacturers are DYSIS Medical Ltd., Abbott Laboratories, Becton, Dickinson and Company, The Cooper Companies, Inc., Danaher Corporation
SEATTLE, May 05, 2021, (PHARMIWEB)
Global Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 5,910.2 million in 2020 and is estimated to register a CAGR over 6.2% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.